Cathy Klema insider trades

Open-market stock purchases and sales by Cathy Klema, Director at OptimizeRx Corp, from SEC Form 4 filings since Jan 4, 2010.

Recent trades

DateStockTradeValue
Jun 9, 2026OPRX OptimizeRx CorpBought (not open market)—

Companies traded

  • OPRX OptimizeRx Corp: other filings, last Jun 9, 2026
  • AGN Allergan plc: other filings, last Apr 30, 2019
  • ACT Actavis plc: 1 sale, last Jun 5, 2015
  • WPI Watson Pharmaceuticals Inc: 2 sales, last Jul 31, 2012
  • PPDI Pharmaceutical Product Development Inc: other filings, last Jan 3, 2011

Get free alerts when Cathy Klema files a new trade →